NCT05372367: A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Solid Tumors